FLURANDRENOLIDE

FLURANDRENOLIDE was reported 333 times

FLURANDRENOLIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BACTERIAL NAIL INFECTION 1 0.1429
1 LARYNGOCELE 1 0.0667
2 MEDIASTINAL CYST 1 0.0556
3 LICHEN NITIDUS 1 0.0286
4 PRODUCT DIFFICULT TO REMOVE 1 0.0167
5 CENTRAL AUDITORY PROCESSING DISORDER 1 0.0167
6 HUMAN CHORIONIC GONADOTROPIN DECREASED 1 0.0090
7 SOLAR URTICARIA 1 0.0079
8 COLOBOMA 1 0.0053
9 PROCEDURAL HYPERTENSION 1 0.0053
10 THYMUS DISORDER 1 0.0052
11 CHRONIC PIGMENTED PURPURA 1 0.0051
12 OCULAR ROSACEA 1 0.0049
13 LEPROSY 1 0.0048
14 SUBSTANCE DEPENDENCE 3 0.0045
15 POST INFLAMMATORY PIGMENTATION CHANGE 2 0.0044
16 VESTIBULAR MIGRAINE 1 0.0041
17 KELOID SCAR 2 0.0039
18 STEROID THERAPY 1 0.0035
19 CUBITAL TUNNEL SYNDROME 1 0.0029
20 KIDNEY MALFORMATION 1 0.0028
21 IMMUNE-MEDIATED CHOLANGITIS 1 0.0028
22 CHRONIC LEFT VENTRICULAR FAILURE 1 0.0028
23 INTESTINAL METASTASIS 1 0.0028
24 HER2 POSITIVE BREAST CANCER 1 0.0027
25 MEDIASTINAL MASS 1 0.0026
26 LUNG DIFFUSION TEST DECREASED 1 0.0025
27 TUMOUR ASSOCIATED FEVER 1 0.0024
28 LICHENIFICATION 1 0.0024
29 PERIOSTITIS 1 0.0023
30 DIVORCED 1 0.0023
31 REFLUX LARYNGITIS 1 0.0023
32 IMPLANT SITE HAEMORRHAGE 1 0.0023
33 SKIN INDENTATION 1 0.0021
34 NAIL RIDGING 1 0.0019
35 TOBACCO ABUSE 1 0.0019
36 MARITAL PROBLEM 1 0.0019
37 HEPATITIS C VIRUS 1 0.0018
38 RENAL TUBULAR DYSFUNCTION 1 0.0018
39 PERFUME SENSITIVITY 1 0.0018
40 NAIL PSORIASIS 1 0.0016
41 VITAMIN D INCREASED 1 0.0016
42 INGROWN HAIR 1 0.0014
43 CONGENITAL HYDRONEPHROSIS 1 0.0014
44 PALMOPLANTAR KERATODERMA 1 0.0014
45 GUTTATE PSORIASIS 1 0.0012
46 COVID-19 IMMUNISATION 1 0.0012
47 HEPATITIS A 1 0.0012
48 MYCOTIC ALLERGY 1 0.0012
49 ARTERIOVENOUS MALFORMATION 1 0.0011
50 PYELOCALIECTASIS 1 0.0010
51 PSYCHOTIC BEHAVIOUR 1 0.0010
52 PRODUCT COATING ISSUE 1 0.0010
53 DERMATITIS PSORIASIFORM 2 0.0010
54 BLADDER DYSFUNCTION 1 0.0010
55 INTERVERTEBRAL DISC COMPRESSION 1 0.0010
56 URETEROLITHIASIS 1 0.0010
57 ALLERGY TO ANIMAL 1 0.0009
58 BLADDER DILATATION 1 0.0009
59 LICHEN PLANUS 2 0.0009
60 PAROTITIS 1 0.0009
61 RENAL TUBULAR INJURY 1 0.0008
62 STAPHYLOCOCCAL SKIN INFECTION 1 0.0008
63 ALLERGY TO CHEMICALS 1 0.0008
64 APPLICATION SITE EROSION 1 0.0008
65 ANAEMIA POSTOPERATIVE 1 0.0008
66 APPLICATION SITE INFLAMMATION 1 0.0007
67 SKIN HYPERTROPHY 2 0.0007
68 JOINT LOCK 2 0.0007
69 POST HERPETIC NEURALGIA 1 0.0007
70 JUDGEMENT IMPAIRED 1 0.0007
71 OBSTRUCTIVE SLEEP APNOEA SYNDROME 1 0.0007
72 CHEST X-RAY ABNORMAL 2 0.0007
73 OSTEOMALACIA 1 0.0006
74 COLONIC POLYP 1 0.0006
75 MITRAL VALVE PROLAPSE 1 0.0006
76 PLANTAR FASCIITIS 2 0.0006
77 SERUM FERRITIN DECREASED 1 0.0006
78 SPINAL CORD INJURY 1 0.0006
79 ROTATOR CUFF REPAIR 1 0.0006
80 SKIN HYPOPIGMENTATION 1 0.0006
81 BEHAVIOUR DISORDER 3 0.0006
82 SUSPECTED PRODUCT QUALITY ISSUE 1 0.0005
83 IMPULSIVE BEHAVIOUR 2 0.0005
84 INFECTED SKIN ULCER 1 0.0005
85 GINGIVAL RECESSION 1 0.0005
86 HEPATIC MASS 1 0.0005
87 SKIN PAPILLOMA 2 0.0005
88 CHOLANGITIS SCLEROSING 1 0.0005
89 PRE-EXISTING CONDITION IMPROVED 3 0.0005
90 POST PROCEDURAL DISCOMFORT 1 0.0005
91 EAR SWELLING 1 0.0005
92 LANGUAGE DISORDER 1 0.0005
93 HERPES SIMPLEX 3 0.0005
94 TONGUE DISCOLOURATION 2 0.0005
95 CORNEAL DISORDER 1 0.0005
96 ONYCHOMYCOSIS 2 0.0005
97 RHINITIS ALLERGIC 2 0.0004
98 BREAKTHROUGH PAIN 1 0.0004
99 IMPLANT SITE INFECTION 1 0.0004
100 VITILIGO 1 0.0004
101 EOSINOPHIL COUNT DECREASED 1 0.0004
102 RASH VESICULAR 2 0.0004
103 DERMAL CYST 1 0.0004
104 BREATH SOUNDS ABNORMAL 2 0.0004
105 DEVICE INFUSION ISSUE 1 0.0004
106 EXCORIATION 1 0.0004
107 LIPOMA 1 0.0004
108 SUBSTANCE ABUSE 3 0.0004
109 SKIN WRINKLING 1 0.0004
110 CLUMSINESS 1 0.0004
111 SKIN INFECTION 4 0.0004
112 VITAMIN B12 DECREASED 1 0.0003
113 SPINAL OSTEOARTHRITIS 3 0.0003
114 SKIN HAEMORRHAGE 5 0.0003
115 CEREBROVASCULAR DISORDER 1 0.0003
116 REBOUND ACID HYPERSECRETION 1 0.0003
117 IRITIS 1 0.0003
118 DERMATITIS ACNEIFORM 2 0.0003
119 DUODENITIS 1 0.0003
120 FIBROSIS 1 0.0003
121 PIGMENTATION DISORDER 2 0.0003
122 NIGHT SWEATS 10 0.0003
123 SKIN FISSURES 6 0.0003
124 PSORIATIC ARTHROPATHY 12 0.0003
125 ECCHYMOSIS 2 0.0003
126 WOUND COMPLICATION 1 0.0003
127 CARPAL TUNNEL SYNDROME 4 0.0003
128 HAND FRACTURE 2 0.0003
129 SKIN WEEPING 1 0.0003
130 SPONDYLITIS 1 0.0003
131 RASH PUSTULAR 2 0.0003
132 DEVICE KINK 1 0.0003
133 MOUTH HAEMORRHAGE 2 0.0003
134 ALCOHOL USE 1 0.0003
135 WOUND HAEMORRHAGE 1 0.0003
136 NEURODERMATITIS 1 0.0003
137 SNORING 1 0.0003
138 THERAPEUTIC PRODUCT INEFFECTIVE 1 0.0003
139 SENSATION OF HEAVINESS 1 0.0003
140 PROSTATOMEGALY 1 0.0003
141 HYPERLIPIDAEMIA 3 0.0003
142 FOREIGN BODY 1 0.0002
143 TRIGEMINAL NEURALGIA 1 0.0002
144 TRIGGER FINGER 1 0.0002
145 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
146 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
147 POOR PERIPHERAL CIRCULATION 1 0.0002
148 PURULENT DISCHARGE 1 0.0002
149 PARONYCHIA 1 0.0002
150 PRODUCT ADHESION ISSUE 8 0.0002
151 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0002
152 SLEEP APNOEA SYNDROME 4 0.0002
153 SUBCUTANEOUS ABSCESS 1 0.0002
154 VITAMIN D DEFICIENCY 2 0.0002
155 APPLICATION SITE BURN 1 0.0002
156 HOSPICE CARE 2 0.0002
157 APPLICATION SITE SWELLING 1 0.0002
158 ECONOMIC PROBLEM 3 0.0002
159 OSTEOPENIA 3 0.0002
160 PATHOLOGICAL FRACTURE 1 0.0002
161 DRY THROAT 2 0.0002
162 AMMONIA INCREASED 1 0.0002
163 PHLEBITIS 1 0.0002
164 FOOD CRAVING 1 0.0002
165 PRODUCT RESIDUE PRESENT 1 0.0002
166 CHEILITIS 1 0.0002
167 OESOPHAGITIS 2 0.0002
168 SKIN LESION 5 0.0002
169 APPLICATION SITE PAIN 4 0.0002
170 HYPERKERATOSIS 1 0.0002
171 STREPTOCOCCAL INFECTION 1 0.0002
172 SKIN TOXICITY 1 0.0002
173 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 3 0.0002
174 CARDIAC VALVE DISEASE 1 0.0002
175 SKIN ATROPHY 1 0.0002
176 METASTASES TO LUNG 2 0.0002
177 SKIN WARM 1 0.0002
178 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
179 CATARACT OPERATION 1 0.0002
180 SINUS HEADACHE 1 0.0002
181 PLATELET COUNT ABNORMAL 1 0.0002
182 INFUSION SITE EXTRAVASATION 1 0.0002
183 SWELLING OF EYELID 1 0.0002
184 MULTIPLE INJURIES 1 0.0002
185 HAEMOGLOBIN ABNORMAL 1 0.0002
186 HIATUS HERNIA 2 0.0002
187 ANGINA UNSTABLE 1 0.0002
188 POLYP 1 0.0002
189 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
190 EAR INFECTION 4 0.0002
191 MALIGNANT MELANOMA 2 0.0001
192 POST-TRAUMATIC STRESS DISORDER 1 0.0001
193 POSTOPERATIVE WOUND INFECTION 1 0.0001
194 ULCER HAEMORRHAGE 1 0.0001
195 MATERNAL EXPOSURE BEFORE PREGNANCY 1 0.0001
196 CORONARY ARTERY OCCLUSION 2 0.0001
197 JOINT EFFUSION 1 0.0001
198 DERMATITIS 3 0.0001
199 PAPULE 1 0.0001
200 PULMONARY TOXICITY 1 0.0001
201 SEASONAL ALLERGY 2 0.0001
202 THERMAL BURN 1 0.0001
203 UTERINE LEIOMYOMA 1 0.0001
204 SENSITIVE SKIN 1 0.0001
205 BONE LOSS 2 0.0001
206 DERMATITIS ATOPIC 7 0.0001
207 AORTIC ANEURYSM 1 0.0001
208 EPILEPSY 4 0.0001
209 LYMPHOMA 2 0.0001
210 TENDONITIS 2 0.0001
211 GASTROINTESTINAL INFLAMMATION 1 0.0001
212 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
213 RENAL CYST 1 0.0001
214 MYASTHENIA GRAVIS 1 0.0001
215 PSORIASIS 16 0.0001
216 HYPERAESTHESIA 1 0.0001
217 MENSTRUAL DISORDER 1 0.0001
218 LIP SWELLING 4 0.0001
219 INFUSION SITE ERYTHEMA 1 0.0001
220 SKIN PLAQUE 1 0.0001
221 CHRONIC KIDNEY DISEASE 9 0.0001
222 PRODUCT CONTAINER ISSUE 1 0.0001
223 SKIN HYPERPIGMENTATION 1 0.0001
224 BLOOD MAGNESIUM DECREASED 1 0.0001
225 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
226 ECZEMA 6 0.0001
227 APPLICATION SITE ERYTHEMA 3 0.0001
228 NAIL DISORDER 1 0.0001
229 IMMUNOSUPPRESSION 1 0.0001
230 DRUG ERUPTION 2 0.0001
231 GASTROINTESTINAL INFECTION 1 0.0001
232 HEAVY MENSTRUAL BLEEDING 1 0.0001
233 LIP DRY 1 0.0001
234 END STAGE RENAL DISEASE 2 0.0001
235 INCREASED TENDENCY TO BRUISE 1 0.0001
236 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
237 PRODUCT DISTRIBUTION ISSUE 1 0.0001
238 SWELLING FACE 7 0.0001
239 HEPATIC STEATOSIS 2 0.0001
240 DIARRHOEA HAEMORRHAGIC 1 0.0001
241 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
242 SKIN EXFOLIATION 9 0.0001
243 LACERATION 1 0.0001
244 SQUAMOUS CELL CARCINOMA 1 0.0001
245 SPUTUM DISCOLOURED 1 0.0001
246 GASTRIC ULCER 2 0.0001
247 ATELECTASIS 1 0.0001
248 ERUCTATION 2 0.0001
249 EAR PAIN 2 0.0001
250 AUTOIMMUNE DISORDER 1 0.0001
251 HEPATOMEGALY 1 0.0001
252 KNEE OPERATION 1 0.0001
253 LIGAMENT SPRAIN 1 0.0001
254 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
255 EMPHYSEMA 1 0.0001
256 CORONARY ARTERY DISEASE 3 0.0001
257 VAGINAL DISCHARGE 1 0.0001
258 BONE DENSITY DECREASED 3 0.0001
259 WEIGHT FLUCTUATION 1 0.0001
260 SCRATCH 1 0.0001
261 JOINT DISLOCATION 1 0.0001
262 OSTEOARTHRITIS 4 0.0001
263 IRRITABLE BOWEL SYNDROME 2 0.0001
264 SKIN LACERATION 1 0.0001
265 MENTAL DISORDER 4 0.0001
266 WOUND INFECTION 1 0.0001
267 FUNGAL INFECTION 3 0.0001
268 DRY SKIN 12 0.0001
269 EYE INFECTION 1 0.0001
270 REBOUND EFFECT 1 0.0001
271 MICTURITION URGENCY 1 0.0001
272 CAESAREAN SECTION 1 0.0001
273 SPLENOMEGALY 1 0.0001
274 COVID-19 PNEUMONIA 1 0.0001
275 BLOOD IRON DECREASED 1 0.0001
276 BACTERAEMIA 1 0.0001
277 ACCIDENT 1 0.0001
278 RASH ERYTHEMATOUS 4 0.0001
279 LOCALISED INFECTION 2 0.0001
280 NOCTURIA 1 0.0001
281 PANIC ATTACK 3 0.0001
282 FIBROMYALGIA 2 0.0001
283 NO THERAPEUTIC RESPONSE 1 0.0001
284 PRURITUS 31 0.0001
285 APPLICATION SITE IRRITATION 1 0.0001
286 DERMATITIS ALLERGIC 1 0.0001
287 DEVICE DEPLOYMENT ISSUE 1 0.0001
288 ROTATOR CUFF SYNDROME 1 0.0001
289 INFLAMMATION 4 0.0001
290 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
291 ANHEDONIA 2 0.0001
292 INCORRECT PRODUCT STORAGE 1 0.0001
293 ANKYLOSING SPONDYLITIS 1 0.0001
294 JOINT RANGE OF MOTION DECREASED 1 0.0001
295 UVEITIS 1 0.0001
296 PALLOR 2 0.0001
297 OSTEOPOROSIS 3 0.0001
298 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
299 APPLICATION SITE RASH 1 0.0001
300 MASS 1 0.0001
301 WOUND 2 0.0001
302 BLISTER 4 0.0001
303 SLEEP DISORDER 5 0.0001
304 LYMPHOPENIA 1 0.0001
305 SKIN BURNING SENSATION 5 0.0001
306 IMPAIRED QUALITY OF LIFE 1 0.0001
307 INJECTION SITE HAEMATOMA 1 0.0001
308 HYPOKINESIA 1 0.0001
309 PULMONARY MASS 1 0.0001
310 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
311 THERAPY NON-RESPONDER 3 0.0001
312 BLOOD COUNT ABNORMAL 1 0.0001
313 DISCOMFORT 4 0.0001
314 HIP ARTHROPLASTY 1 0.0001
315 FEELING HOT 4 0.0001
316 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
317 MUSCULOSKELETAL CHEST PAIN 1 0.0001
318 PARAESTHESIA 10 0.0001
319 HEAD INJURY 2 0.0001
320 PNEUMOTHORAX 1 0.0001
321 PRODUCTIVE COUGH 3 0.0001
322 CYSTITIS 2 0.0001
323 OBESITY 1 0.0001
324 SENSORY DISTURBANCE 1 0.0001
325 DEPRESSION 14 0.0001
326 MULTIPLE FRACTURES 1 0.0001
327 PHOTOSENSITIVITY REACTION 1 0.0001
328 DRY EYE 3 0.0001
329 VIRAL INFECTION 2 0.0001
330 LEUKOPENIA 3 0.0001
331 SKIN DISORDER 2 0.0001
332 CELLULITIS 3 0.0001
333 GASTRIC DISORDER 2 0.0001
334 MUSCULOSKELETAL DISCOMFORT 1 0.0001
335 RASH MACULAR 2 0.0001
336 GOUT 1 0.0001
337 GASTROENTERITIS VIRAL 1 0.0001
338 CRYING 2 0.0001
339 HAEMATOCHEZIA 3 0.0001
340 BRONCHITIS 4 0.0001
341 CONJUNCTIVITIS 1 0.0001
342 URTICARIA 9 0.0001
343 BACTERIAL INFECTION 1 0.0001
344 MIDDLE INSOMNIA 1 0.0001
345 HEPATIC CIRRHOSIS 1 0.0001
346 FRACTURE 1 0.0001
347 FOOT FRACTURE 1 0.0001
348 BLOOD URINE PRESENT 1 0.0001
349 NEUROPATHY PERIPHERAL 5 0.0001
350 MUSCULOSKELETAL DISORDER 1 0.0001
351 INCREASED APPETITE 1 0.0001
352 HERPES ZOSTER 3 0.0001
353 POST PROCEDURAL COMPLICATION 1 0.0001
354 DRUG PRESCRIBING ERROR 1 0.0001
355 LOWER LIMB FRACTURE 1 0.0001
356 GLAUCOMA 1 0.0001
357 HERNIA 1 0.0001
358 HAEMORRHOIDS 1 0.0001
359 ORAL HERPES 1 0.0001
360 SURGERY 3 0.0001
361 HAEMATOCRIT DECREASED 1 0.0001
362 UPPER LIMB FRACTURE 1 0.0001
363 PREGNANCY 1 0.0000
364 THROMBOSIS 4 0.0000
365 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
366 PRODUCT PHYSICAL ISSUE 1 0.0000
367 THERAPEUTIC RESPONSE DECREASED 3 0.0000
368 PLEURAL EFFUSION 3 0.0000
369 VERTIGO 3 0.0000
370 NASOPHARYNGITIS 9 0.0000
371 SINUSITIS 5 0.0000
372 HAEMOGLOBIN DECREASED 5 0.0000
373 RIB FRACTURE 1 0.0000
374 DRUG DOSE OMISSION 8 0.0000
375 RHABDOMYOLYSIS 2 0.0000
376 PAIN IN EXTREMITY 14 0.0000
377 HALLUCINATION, VISUAL 1 0.0000
378 EATING DISORDER 1 0.0000
379 URINARY TRACT INFECTION 8 0.0000
380 IMPAIRED WORK ABILITY 1 0.0000
381 SKIN CANCER 1 0.0000
382 DEEP VEIN THROMBOSIS 3 0.0000
383 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
384 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
385 INFLUENZA 5 0.0000
386 INJECTION SITE PRURITUS 3 0.0000
387 SNEEZING 1 0.0000
388 APPLICATION SITE PRURITUS 1 0.0000
389 MUSCULAR WEAKNESS 5 0.0000
390 SUICIDAL IDEATION 4 0.0000
391 NEPHROLITHIASIS 2 0.0000
392 INJECTION SITE REACTION 3 0.0000
393 RASH 19 0.0000
394 SKIN DISCOLOURATION 2 0.0000
395 MUSCLE TWITCHING 1 0.0000
396 OROPHARYNGEAL PAIN 4 0.0000
397 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
398 PALPITATIONS 5 0.0000
399 ANXIETY 12 0.0000
400 PRESYNCOPE 1 0.0000
401 CEREBRAL INFARCTION 1 0.0000
402 INJECTION SITE URTICARIA 1 0.0000
403 ENCEPHALOPATHY 1 0.0000
404 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
405 AGGRESSION 2 0.0000
406 COVID-19 7 0.0000
407 HOT FLUSH 3 0.0000
408 GASTRIC CANCER 1 0.0000
409 FLUSHING 4 0.0000
410 CHEST DISCOMFORT 4 0.0000
411 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
412 ANAPHYLACTIC SHOCK 1 0.0000
413 SKIN ULCER 1 0.0000
414 RASH GENERALISED 1 0.0000
415 DIPLOPIA 1 0.0000
416 DEAFNESS 1 0.0000
417 MUCOSAL INFLAMMATION 1 0.0000
418 MUSCULOSKELETAL PAIN 2 0.0000
419 DEPRESSED MOOD 2 0.0000
420 HYPERSENSITIVITY 7 0.0000
421 RENAL FAILURE 5 0.0000
422 INSOMNIA 10 0.0000
423 BREAST CANCER FEMALE 1 0.0000
424 PAIN OF SKIN 1 0.0000
425 DRUG EFFECT DECREASED 2 0.0000
426 DISTURBANCE IN ATTENTION 2 0.0000
427 THROAT TIGHTNESS 1 0.0000
428 PRODUCT QUALITY ISSUE 5 0.0000
429 MOOD ALTERED 1 0.0000
430 TREATMENT NONCOMPLIANCE 2 0.0000
431 PRODUCT USE IN UNAPPROVED INDICATION 9 0.0000
432 ABNORMAL DREAMS 1 0.0000
433 FEELING COLD 1 0.0000
434 RENAL IMPAIRMENT 3 0.0000
435 ALOPECIA 7 0.0000
436 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
437 ASTHMA 4 0.0000
438 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
439 PAIN IN JAW 1 0.0000
440 ANGINA PECTORIS 1 0.0000
441 BALANCE DISORDER 3 0.0000
442 BACK PAIN 8 0.0000
443 DRUG WITHDRAWAL SYNDROME 3 0.0000
444 NASAL CONGESTION 2 0.0000
445 URINARY INCONTINENCE 1 0.0000
446 RENAL INJURY 1 0.0000
447 RESPIRATORY DISORDER 1 0.0000
448 HYPOAESTHESIA 5 0.0000
449 BLOOD POTASSIUM DECREASED 1 0.0000
450 APHASIA 1 0.0000
451 LACRIMATION INCREASED 1 0.0000
452 INJECTION SITE RASH 1 0.0000
453 VISUAL IMPAIRMENT 4 0.0000
454 SWELLING 3 0.0000
455 HEADACHE 20 0.0000
456 DRUG-INDUCED LIVER INJURY 1 0.0000
457 DYSPHAGIA 3 0.0000
458 CONTUSION 3 0.0000
459 MOVEMENT DISORDER 1 0.0000
460 HYPERHIDROSIS 4 0.0000
461 PRODUCT DOSE OMISSION 2 0.0000
462 OSTEONECROSIS 1 0.0000
463 STAPHYLOCOCCAL INFECTION 1 0.0000
464 HEART RATE INCREASED 3 0.0000
465 INFUSION RELATED REACTION 2 0.0000
466 EXPIRED PRODUCT ADMINISTERED 1 0.0000
467 SYNCOPE 3 0.0000
468 ABDOMINAL DISCOMFORT 5 0.0000
469 EYE PRURITUS 1 0.0000
470 HEPATIC ENZYME INCREASED 2 0.0000
471 PAIN 18 0.0000
472 HAEMATURIA 1 0.0000
473 ERYTHEMA 6 0.0000
474 NEOPLASM PROGRESSION 1 0.0000
475 HYPOXIA 1 0.0000
476 LYMPHADENOPATHY 1 0.0000
477 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
478 MOBILITY DECREASED 2 0.0000
479 INFECTION 4 0.0000
480 AGITATION 2 0.0000
481 DYSURIA 1 0.0000
482 CHEST PAIN 5 0.0000
483 DIABETES MELLITUS 2 0.0000
484 ANAEMIA 5 0.0000
485 BLOOD PRESSURE INCREASED 4 0.0000
486 ACUTE KIDNEY INJURY 4 0.0000
487 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
488 CHILLS 3 0.0000
489 NAUSEA 20 0.0000
490 DIARRHOEA 16 0.0000
491 EMOTIONAL DISTRESS 3 0.0000
492 DYSPNOEA 14 0.0000
493 NEUTROPHIL COUNT DECREASED 1 0.0000
494 TREATMENT FAILURE 2 0.0000
495 TREMOR 4 0.0000
496 DIZZINESS 12 0.0000
497 FALL 8 0.0000
498 ROAD TRAFFIC ACCIDENT 1 0.0000
499 PRODUCT DOSE OMISSION ISSUE 7 0.0000
500 HYPERTENSION 5 0.0000
501 HYPOACUSIS 1 0.0000
502 FATIGUE 18 0.0000
503 VAGINAL HAEMORRHAGE 1 0.0000
504 CONSTIPATION 5 0.0000
505 PRODUCT STORAGE ERROR 2 0.0000
506 INTENTIONAL PRODUCT MISUSE 2 0.0000
507 DRUG INEFFECTIVE 30 0.0000
508 TACHYCARDIA 2 0.0000
509 WEIGHT INCREASED 5 0.0000
510 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
511 THROAT IRRITATION 1 0.0000
512 NEUTROPENIA 3 0.0000
513 VISION BLURRED 3 0.0000
514 SKIN IRRITATION 1 0.0000
515 TINNITUS 1 0.0000
516 HYPOKALAEMIA 1 0.0000
517 ARTHRALGIA 9 0.0000
518 RENAL DISORDER 1 0.0000
519 BLOOD CHOLESTEROL INCREASED 1 0.0000
520 PRODUCT USE ISSUE 4 0.0000
521 ASTHENIA 8 0.0000
522 VOMITING 10 0.0000
523 OCULAR HYPERAEMIA 1 0.0000
524 PULMONARY EMBOLISM 2 0.0000
525 DISEASE RECURRENCE 1 0.0000
526 MULTIPLE SCLEROSIS 1 0.0000
527 GAIT DISTURBANCE 4 0.0000
528 INTERSTITIAL LUNG DISEASE 1 0.0000
529 LUNG DISORDER 1 0.0000
530 CONDITION AGGRAVATED 6 0.0000
531 FLUID RETENTION 1 0.0000
532 INJECTION SITE PAIN 6 0.0000
533 NERVOUSNESS 1 0.0000
534 PANCREATITIS 1 0.0000
535 DRUG INTERACTION 3 0.0000
536 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
537 DRUG DEPENDENCE 3 0.0000
538 PNEUMONIA 6 0.0000
539 OEDEMA 1 0.0000
540 ANAPHYLACTIC REACTION 1 0.0000
541 ARTHROPATHY 1 0.0000
542 WEIGHT DECREASED 5 0.0000
543 NECK PAIN 1 0.0000
544 COUGH 5 0.0000
545 OXYGEN SATURATION DECREASED 1 0.0000
546 EYE PAIN 1 0.0000
547 INCORRECT DOSE ADMINISTERED 4 0.0000
548 LETHARGY 1 0.0000
549 EYE IRRITATION 1 0.0000
550 PRODUCT SUBSTITUTION ISSUE 1 0.0000
551 PYREXIA 6 0.0000
552 MYOCARDIAL INFARCTION 3 0.0000
553 DYSPHONIA 1 0.0000
554 BLADDER CANCER 1 0.0000
555 DISEASE PROGRESSION 2 0.0000
556 WHEEZING 1 0.0000
557 CATARACT 1 0.0000
558 IRRITABILITY 1 0.0000
559 SUICIDE ATTEMPT 1 0.0000
560 STOMATITIS 1 0.0000
561 ILL-DEFINED DISORDER 1 0.0000
562 OEDEMA PERIPHERAL 2 0.0000
563 MALAISE 7 0.0000
564 INTENTIONAL OVERDOSE 1 0.0000
565 RHINORRHOEA 1 0.0000
566 DEVICE EXPULSION 1 0.0000
567 BLOOD CREATININE INCREASED 1 0.0000
568 DEVICE DIFFICULT TO USE 1 0.0000
569 DEHYDRATION 2 0.0000
570 OFF LABEL USE 13 0.0000
571 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
572 MEMORY IMPAIRMENT 2 0.0000
573 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
574 THERAPY INTERRUPTED 1 0.0000
575 EPISTAXIS 1 0.0000
576 HALLUCINATION 1 0.0000
577 ACNE 1 0.0000
578 INJECTION SITE SWELLING 1 0.0000
579 HOSPITALISATION 2 0.0000
580 PERIPHERAL SWELLING 2 0.0000
581 DECREASED APPETITE 3 0.0000
582 ABDOMINAL PAIN 3 0.0000
583 ARTHRITIS 1 0.0000
584 INJECTION SITE BRUISING 1 0.0000
585 CARDIAC FAILURE 1 0.0000
586 CARDIAC FAILURE CONGESTIVE 1 0.0000
587 INFLUENZA LIKE ILLNESS 1 0.0000
588 DRUG ABUSE 1 0.0000
589 COMPLETED SUICIDE 1 0.0000
590 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
591 MYALGIA 2 0.0000
592 MUSCULOSKELETAL STIFFNESS 1 0.0000
593 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
594 MUSCLE SPASMS 2 0.0000
595 CARDIAC DISORDER 1 0.0000
596 ABDOMINAL PAIN UPPER 2 0.0000
597 ILLNESS 1 0.0000
598 HAEMORRHAGE 1 0.0000
599 PLATELET COUNT DECREASED 1 0.0000
600 THROMBOCYTOPENIA 1 0.0000
601 SEIZURE 1 0.0000
602 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
603 JOINT SWELLING 1 0.0000
604 INJECTION SITE ERYTHEMA 1 0.0000
605 CONFUSIONAL STATE 1 0.0000
606 CEREBROVASCULAR ACCIDENT 1 0.0000
607 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
608 BLOOD GLUCOSE INCREASED 1 0.0000
609 SOMNOLENCE 1 0.0000
610 FEELING ABNORMAL 1 0.0000
611 DEATH 2 0.0000